The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global plastic surgery instruments market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 8% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Plastic surgery instruments are manufactured using a variety of materials, such as fiber and metal. These instruments are non-corrosive, non-allergenic and sterilizable and assist in performing surgical procedures on different parts of the body, such as the craniomaxillofacial and musculoskeletal. At present, the demand for plastic surgery instruments is rising around the world due to the increasing willingness among individuals to undergo reconstructive and cosmetic surgeries.
The market is experiencing significant growth on account of the increasing consciousness about physical appearances, particularly among the aging population who wish to restore their saggy skin and look younger. This trend is further supported by the ability of these surgeries to preserve vascularity, heal wounds, and enhance the aesthetic and functional well-being of the body, and thereby increasing the confidence level of individuals. Apart from this, the growing preference for minimally invasive (MI) procedures is also escalating the market growth. Moreover, advancements in tissue engineering, gene therapy, alloplastic materials and computer-assisted imaging technology are bolstering innovation in plastic surgery procedures. However, the market growth is experiencing a negative impact due to a surge in the cases of the coronavirus disease (COVID-19) and lockdowns imposed by governments in most of the countries as a preventive measure. They have also restricted operations of all non-essential activities, which has declined the practice of plastic surgeries across the globe. The market is anticipated to experience growth once normalcy is regained.
IMARC Group provides an analysis of the key trends in each sub-segment of the global plastic surgery instruments market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on type, procedure and end user.
Breakup by Type:
Breakup by Procedure:
Breakup by End User:
Breakup by Region:
The report has also analysed the competitive landscape of the market with some of the key players being Anthony Products Inc., B. Braun Melsungen Aktiengesellschaft (B. Braun Holding GmbH & Co. KG), Blink Medical, BMT Medizintechnik GmbH, Bolton Surgical Ltd., Integra Lifesciences Holdings Corporation, Karl Storz SE & Co. KG, Sklar Corporation, Tekno-Medical Optik-Chirurgie GmbH and Zimmer Biomet Holdings Inc.
|Base Year of the Analysis||2020|
|Segment Coverage||Type, Procedure, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Anthony Products Inc., B. Braun Melsungen Aktiengesellschaft (B. Braun Holding GmbH & Co. KG), Blink Medical, BMT Medizintechnik GmbH, Bolton Surgical Ltd., Integra Lifesciences Holdings Corporation, Karl Storz SE & Co. KG, Sklar Corporation, Tekno-Medical Optik-Chirurgie GmbH and Zimmer Biomet Holdings Inc.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Key Questions Answered in This Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at